Salivary gland hypofunction negatively impacts normal speech,
mastication and general oral health. A significant proportion of these
cases are of unknown origin (idiopathic). Our central hypothesis is that
many of these cases reflect a disruption of the normal signaling pathways
regulating the stimulation of salivary flow. The major mechanisms of
stimulation of salivary gland fluid secretion involves muscarinic receptor-
induced increases in intracellular Ca2+ concentration ([Ca2+]i), via
activation of the phospholipase C/inositol triphosphate (PLC/InsP3)
pathway, the details of which are fairly well-established. However, a
substantial body evidence indicates the importance of a concurrent
activation of cyclic AMP/protein kinase A (cAMP/PKA) signaling
pathways along with the PLC/InsP3 pathway. This simultaneous
activation of the two pathways profoundly potentiates overall fluid
secretion via a mechanism that is, as yet, unclear. It is our hypothesis that
proteins involved in this interaction are likely loci fort the underlying
disruption seen in the diseased state. A major goal of this project is
therefore to identify the key points of convergence of the two pathways in
parotid acinar cells. Mouse parotid acinar cells will be utilized as a model
system, however, the validity of the model will be confirmed in human
tissue when available. We will examine the effects of PKA linked
agonists on the generation and turnover of Insp3, and on the specific
temporal and spatial features of the [Ca2+]i signals evoked by PLC-
coupled agonists, both within and between acinar cells. The underlying
mechanisms will be analyzed by identifying the molecular species and
sub-cellular location of the individual signaling components involved,
and by determining the properties of their regulation by PKA. In addition,
potential interactions between PKA- and PLC-linked agonists at the level
of the C1- and K+ conductances and the basolateral Na-2Cl-K co-
transporter will be considered. The effects of potentiating combinations of
agonists on the activation and modulation of individual Cl- and K+
conductances will be investigated, specifically focusing on those
conductances demonstrated to be the most relevant in Subproject 2, and
the nature of the effects determined. The activity of the co-transporter will
also be assessed to determine if this is a potential site for potentiation by
PKA-linked agonists. It is envisioned that these studies will identify loci
which underlie the physiologically important regulation of salivary
secretion, thereby increasing our understanding of the etiology of salivary
gland dysfunction with a long term goal of designing effective therapies.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
acinar cellbiological signal transductioncalcium fluxgenetic disorderhuman tissuelaboratory mousemembrane transport proteinsmuscarinic receptorparotid glandphospholipase Cprotein kinase Asalivasalivary glandssecretionsodium potassium exchanging ATPasexerostomias
National Institute of Dental and Craniofacial Research
CFDA Code
DUNS Number
041294109
UEI
F27KDXZMF9Y8
Project Start Date
01-April-2002
Project End Date
31-March-2003
Budget Start Date
Budget End Date
Project Funding Information for 2002
Total Funding
$135,499
Direct Costs
$135,499
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2002
National Institute of Dental and Craniofacial Research
$135,499
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P01DE013539-03 0001
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P01DE013539-03 0001
Patents
No Patents information available for 5P01DE013539-03 0001
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P01DE013539-03 0001
Clinical Studies
No Clinical Studies information available for 5P01DE013539-03 0001
News and More
Related News Releases
No news release information available for 5P01DE013539-03 0001
History
No Historical information available for 5P01DE013539-03 0001
Similar Projects
No Similar Projects information available for 5P01DE013539-03 0001